Doctors track blood product use in heart surgery to find best practices
NCT ID NCT06395480
Summary
This study aims to understand how doctors currently use fluids and a blood product called albumin in patients undergoing heart surgery. Researchers will observe 104 patients across multiple hospitals to see when, why, and how much of these products are given. The information will be used to design better future studies to determine the safest and most effective ways to manage fluids after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTITHROMBIN III LEVELS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kingston Health Sciences Centre
Kingston, Ontario, K7L 3N6, Canada
-
Toronto General Hospital - University Health Network
Toronto, Ontario, M5G 2C4, Canada
Conditions
Explore the condition pages connected to this study.